[
  {
    "ts": "2025-10-07T15:20:00+00:00",
    "headline": "Neuromuscular Disease Therapeutics Market to Reach US$ 45.62 Billion by 2033 as Gene Therapies and RNA-based Treatments Redefine Patient Outcomes",
    "summary": "The Neuromuscular Disease Therapeutics Market is entering a period of accelerated growth, supported by breakthroughs in gene therapy, antisense oligonucleotides (ASOs), monoclonal antibodies, and small-molecule modulators. According to DataM Intelligence, the Neuromuscular Disease Therapeutics Market Size reached US$ 11.89 billion in 2023, rose to US$ 13.70 billion in 2024, and is projected to reach US$ 45.62 billion by 2033, growing at a CAGR of 14.4% during 2025–2033.",
    "url": "https://finance.yahoo.com/news/neuromuscular-disease-therapeutics-market-reach-152000966.html",
    "source": "PR Newswire",
    "provider": "yfinance",
    "raw": {
      "id": "f9e031e4-803b-3103-83ca-4e000d143ba0",
      "content": {
        "id": "f9e031e4-803b-3103-83ca-4e000d143ba0",
        "contentType": "STORY",
        "title": "Neuromuscular Disease Therapeutics Market to Reach US$ 45.62 Billion by 2033 as Gene Therapies and RNA-based Treatments Redefine Patient Outcomes",
        "description": "",
        "summary": "The Neuromuscular Disease Therapeutics Market is entering a period of accelerated growth, supported by breakthroughs in gene therapy, antisense oligonucleotides (ASOs), monoclonal antibodies, and small-molecule modulators. According to DataM Intelligence, the Neuromuscular Disease Therapeutics Market Size reached US$ 11.89 billion in 2023, rose to US$ 13.70 billion in 2024, and is projected to reach US$ 45.62 billion by 2033, growing at a CAGR of 14.4% during 2025–2033.",
        "pubDate": "2025-10-07T15:20:00Z",
        "displayTime": "2025-10-07T15:20:00Z",
        "isHosted": true,
        "bypassModal": false,
        "previewUrl": null,
        "thumbnail": {
          "originalUrl": "https://media.zenfs.com/en/prnewswire.com/d8629f10a81077edae7ba074dc4e4acd",
          "originalWidth": 400,
          "originalHeight": 400,
          "caption": "DataM Intelligence 4 Market Research LLP Logo",
          "resolutions": [
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/tAyZzQodmbAzF2vHT0G.Dg--~B/aD00MDA7dz00MDA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/prnewswire.com/d8629f10a81077edae7ba074dc4e4acd.cf.webp",
              "width": 400,
              "height": 400,
              "tag": "original"
            },
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/gVv0fgg5FCouR0nL5tGSQw--~B/Zmk9c3RyaW07aD0xMjg7dz0xNzA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/prnewswire.com/d8629f10a81077edae7ba074dc4e4acd.cf.webp",
              "width": 170,
              "height": 128,
              "tag": "170x128"
            }
          ]
        },
        "provider": {
          "displayName": "PR Newswire",
          "url": "https://www.prnewswire.com/"
        },
        "canonicalUrl": {
          "url": "https://finance.yahoo.com/news/neuromuscular-disease-therapeutics-market-reach-152000966.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "clickThroughUrl": {
          "url": "https://finance.yahoo.com/news/neuromuscular-disease-therapeutics-market-reach-152000966.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "metadata": {
          "editorsPick": false
        },
        "finance": {
          "stockTickers": [
            {
              "symbol": "NOVN.SW"
            },
            {
              "symbol": "BIIB"
            },
            {
              "symbol": "ABBV"
            },
            {
              "symbol": "AZN.L"
            },
            {
              "symbol": "4502.T"
            },
            {
              "symbol": "SRPT"
            }
          ],
          "premiumFinance": {
            "isPremiumNews": false,
            "isPremiumFreeNews": false
          }
        },
        "storyline": null
      }
    }
  },
  {
    "ts": "2025-10-07T15:00:00+00:00",
    "headline": "Rare Disease Therapeutics Market to Surpass US$ 495.27 Billion by 2033 as Gene Therapy, RNA-based Drugs, and Biologics Transform Patient Care",
    "summary": "The Rare Disease Therapeutics Market is experiencing an unprecedented wave of innovation, driven by gene therapies, RNA-based treatments, enzyme replacement therapies (ERTs), and targeted biologics. According to DataM Intelligence, the Rare Disease Therapeutics Market Size reached US$ 135.88 billion in 2023, rose to US$ 154.64 billion in 2024, and is projected to reach US$ 495.27 billion by 2033, expanding at a CAGR of 13.8% during 2025–2033.",
    "url": "https://finance.yahoo.com/news/rare-disease-therapeutics-market-surpass-150000687.html",
    "source": "PR Newswire",
    "provider": "yfinance",
    "raw": {
      "id": "70003570-c6cb-3e4d-8465-f344265eeeac",
      "content": {
        "id": "70003570-c6cb-3e4d-8465-f344265eeeac",
        "contentType": "STORY",
        "title": "Rare Disease Therapeutics Market to Surpass US$ 495.27 Billion by 2033 as Gene Therapy, RNA-based Drugs, and Biologics Transform Patient Care",
        "description": "",
        "summary": "The Rare Disease Therapeutics Market is experiencing an unprecedented wave of innovation, driven by gene therapies, RNA-based treatments, enzyme replacement therapies (ERTs), and targeted biologics. According to DataM Intelligence, the Rare Disease Therapeutics Market Size reached US$ 135.88 billion in 2023, rose to US$ 154.64 billion in 2024, and is projected to reach US$ 495.27 billion by 2033, expanding at a CAGR of 13.8% during 2025–2033.",
        "pubDate": "2025-10-07T15:00:00Z",
        "displayTime": "2025-10-07T15:00:00Z",
        "isHosted": true,
        "bypassModal": false,
        "previewUrl": null,
        "thumbnail": {
          "originalUrl": "https://media.zenfs.com/en/prnewswire.com/d8629f10a81077edae7ba074dc4e4acd",
          "originalWidth": 400,
          "originalHeight": 400,
          "caption": "DataM Intelligence Logo",
          "resolutions": [
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/tAyZzQodmbAzF2vHT0G.Dg--~B/aD00MDA7dz00MDA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/prnewswire.com/d8629f10a81077edae7ba074dc4e4acd.cf.webp",
              "width": 400,
              "height": 400,
              "tag": "original"
            },
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/gVv0fgg5FCouR0nL5tGSQw--~B/Zmk9c3RyaW07aD0xMjg7dz0xNzA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/prnewswire.com/d8629f10a81077edae7ba074dc4e4acd.cf.webp",
              "width": 170,
              "height": 128,
              "tag": "170x128"
            }
          ]
        },
        "provider": {
          "displayName": "PR Newswire",
          "url": "https://www.prnewswire.com/"
        },
        "canonicalUrl": {
          "url": "https://finance.yahoo.com/news/rare-disease-therapeutics-market-surpass-150000687.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "clickThroughUrl": {
          "url": "https://finance.yahoo.com/news/rare-disease-therapeutics-market-surpass-150000687.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "metadata": {
          "editorsPick": false
        },
        "finance": {
          "stockTickers": [
            {
              "symbol": "ROG.SW"
            },
            {
              "symbol": "NOVN.SW"
            },
            {
              "symbol": "PFE"
            },
            {
              "symbol": "4502.T"
            },
            {
              "symbol": "SAN.PA"
            },
            {
              "symbol": "BIIB"
            }
          ],
          "premiumFinance": {
            "isPremiumNews": false,
            "isPremiumFreeNews": false
          }
        },
        "storyline": null
      }
    }
  }
]